$VCYT
Veracyte (VCYT) Insider Trading
Veracyte, Inc.Mid Cap$4.2B
Veracyte insiders sold $22.6M in the last 12 months, mostly under preset 10b5-1 plans, led by Marc Stapley, with no insider purchases.
View trades →
Insiders (12-Month)
11 Insiders
View trades →
Insider Buys (12-Month)
No insider buys
Latest Buy
No open-market buys on record
View trades →
Politicians (12-Month)
1 buy · 1 sell
Latest: Rep. Cisneros (D-CA)bought $1K–15K
Mar 3, '26
Recent Insider Trades in VCYT
| Type | Insider | Role | Price | Shares | ΔOwn | Value | Filed |
|---|---|---|---|---|---|---|---|
SELLOE+Sale10b5-1 | Holstein Jens | Director | $48.50 | 15,000 | −35.3% | -$727,500 | Oct 28, '26 |
SELLOE+Sale10b5-1 | Eastham Karin | Director | $50.00 | 14,850 | −59.2% | -$742,573 | Oct 28, '26 |
SELL10b5-1 | Bhanji Muna | Director | $43.70 | 1,864 | −4.4% | -$81,457 | Oct 20, '26 |
SELL10b5-1 | Leite John | Global Chief Commercial Off | $40.00 | 4,015 | −3.1% | -$160,600 | Sep 22, '26 |
SELL10b5-1 | Holstein Jens | Director | $40.95 | 5,000 | −15.4% | -$204,747 | Sep 16, '26 |
SELL10b5-1 | Febbo Phillip G. | Chief Scientific & Med Officer | $43.05 | 13,110 | −9.0% | -$564,410 | Sep 4, '26 |
SELL10b5-1 | Chambers Rebecca | CFO | $43.10 | 3,652 | −2.2% | -$157,394 | Sep 4, '26 |
SELL10b5-1 | McGuire Annie | EVP, General Counsel | $43.09 | 3,254 | −2.4% | -$140,212 | Sep 4, '26 |
SELL10b5-1 | Bhanji Muna | Director | $42.97 | 1,864 | −4.2% | -$80,096 | Sep 3, '26 |
SELL10b5-1 | Eastham Karin | Director | $52.89 | 3,729 | −19.8% | -$197,234 | Jun 22, '26 |
SELL10b5-1 | McGuire Annie | EVP, General Counsel | $49.76 | 3,176 | −2.3% | -$158,036 | Jun 5, '26 |
SELL10b5-1 | Chambers Rebecca | CFO | $49.73 | 3,561 | −2.0% | -$177,083 | Jun 5, '26 |
SELLOE+Sale10b5-1 | Stapley Marc | CEO | $50.12 | 138,051 | −23.9% | -$6,919,585 | Jun 5, '26 |
SELL10b5-1 | Leite John | Global Chief Commercial Off | $50.07 | 13,975 | −9.6% | -$699,732 | Jun 5, '26 |
SELLOE+Sale | Wygant Jonathan | VP, CAO | $45.40 | 24,000 | −34.6% | -$1,089,624 | May 27, '26 |
SELL10b5-1 | Epstein Robert S | Director | $44.01 | 10,000 | −16.0% | -$440,129 | May 22, '26 |
SELL10b5-1 | McGuire Annie | SVP, General Counsel | $39.02 | 10,204 | −6.6% | -$398,211 | May 8, '26 |
SELL10b5-1 | Chambers Rebecca | CFO | $36.14 | 18,341 | −12.3% | -$662,869 | Mar 6, '26 |
SELL10b5-1 | Stapley Marc | CEO | $35.97 | 45,523 | −11.3% | -$1,637,594 | Mar 6, '26 |
SELL10b5-1 | Leite John | CCO-CLIA | $35.19 | 5,260 | −4.7% | -$185,083 | Mar 6, '26 |
SELL10b5-1 | McGuire Annie | SVP, General Counsel | $35.55 | 6,658 | −6.6% | -$236,725 | Mar 6, '26 |
SELL10b5-1 | Febbo Phillip G. | Chief Scientific & Med Officer | $36.16 | 13,425 | −10.3% | -$485,429 | Mar 4, '26 |
SELL10b5-1 | McGuire Annie | SVP, General Counsel | $43.13 | 10,739 | −13.7% | -$463,204 | Dec 17, '25 |
SELLOE+Sale10b5-1 | Eastham Karin | Director | $45.45 | 20,000 | −59.6% | -$908,923 | Dec 8, '25 |
SELL10b5-1 | McGuire Annie | SVP, General Counsel | $47.30 | 1,422 | −1.8% | -$67,261 | Dec 5, '25 |
SELL10b5-1 | Chambers Rebecca | CFO | $46.84 | 13,278 | −10.8% | -$621,955 | Dec 5, '25 |
SELL10b5-1 | Stapley Marc | CEO | $47.09 | 7,668 | −2.4% | -$361,076 | Dec 5, '25 |
SELL10b5-1 | Leite John | CCO-CLIA | $47.51 | 1,278 | −1.5% | -$60,718 | Dec 5, '25 |
SELL10b5-1 | Leite John | CCO-CLIA | $50.00 | 2,808 | −3.2% | -$140,400 | Nov 26, '25 |
SELL10b5-1 | Jones Evan/ Fa | Director | $50.25 | 1,106 | −3.6% | -$55,576 | Nov 26, '25 |
SELL10b5-1 | Holstein Jens | Director | $42.36 | 10,000 | −26.9% | -$423,563 | Nov 21, '25 |
SELL | Wygant Jonathan | VP, CAO | $41.20 | 10,920 | −22.0% | -$449,907 | Nov 12, '25 |
SELL10b5-1 | McGuire Annie | SVP, General Counsel | $40.00 | 6,466 | −7.2% | -$258,640 | Nov 7, '25 |
SELLOE+Sale10b5-1 | Jones Evan/ Fa | Director | $45.06 | 43,196 | −58.6% | -$1,946,288 | Nov 7, '25 |
SELL10b5-1 | Eastham Karin | Director | $40.02 | 9,674 | −41.6% | -$387,191 | Nov 7, '25 |
SELL10b5-1 | Chambers Rebecca | CFO | $41.00 | 7,000 | −5.3% | -$287,000 | Nov 7, '25 |
Older than 12 months | |||||||
SELL10b5-1 | Febbo Phillip G. | Chief Scientific & Med Officer | $36.02 | 8,349 | −8.3% | -$300,709 | Oct 7, '25 |
SELL10b5-1 | Leite John | CCO-CLIA | $35.00 | 2,539 | −2.8% | -$88,865 | Oct 3, '25 |
SELLOE+Sale10b5-1 | Epstein Robert S | Director | $35.08 | 21,473 | −25.6% | -$753,204 | Oct 3, '25 |
SELL10b5-1 | McGuire Annie | SVP, General Counsel | $35.00 | 2,160 | −2.4% | -$75,608 | Oct 3, '25 |
SELL10b5-1 | McGuire Annie | SVP, General Counsel | $33.69 | 2,283 | −2.4% | -$76,920 | Sep 23, '25 |
SELL10b5-1 | Stapley Marc | CEO | $30.41 | 7,667 | −2.2% | -$233,133 | Sep 8, '25 |